Results 151 to 160 of about 1,444,902 (214)
Bacteriophages from human skin infecting coagulase-negative Staphylococcus: diversity, novelty and host resistance. [PDF]
Sci RepAlsaadi SE +5 more
europepmc +1 more source
RECON gene disruption enhances host resistance to enable genome-wide evaluation of intracellular pathogen fitness during infection. [PDF]
mBioStamm CE +6 more
europepmc +1 more source
Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistance. [PDF]
Infect ImmunLarson EC +20 more
europepmc +1 more source
Long-Term Treatment with Alcaligenes faecalis A12C Improves Host Resistance to Pathogens in Septic Rats: Possible Contribution of Curdlan-Like Immune Trainer. [PDF]
Probiotics Antimicrob ProteinsMartel-Benítez CJ +17 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2018
The goal of immunotoxicity testing is to obtain data useful for immunotoxicity safety assessment. Guidance in the performance of immunotoxicity safety evaluations is provided in documents from the US EPA for chemicals and the ICH S8 document for pharmaceuticals.
Stefanie C M, Burleson +5 more
openaire +2 more sources
The goal of immunotoxicity testing is to obtain data useful for immunotoxicity safety assessment. Guidance in the performance of immunotoxicity safety evaluations is provided in documents from the US EPA for chemicals and the ICH S8 document for pharmaceuticals.
Stefanie C M, Burleson +5 more
openaire +2 more sources
Australian and New Zealand Journal of Surgery, 1967
Summary1. Experimental studies on immunity to tumours in animals show that tumour growth is modified by an immunological reaction provided that the immunological system of the host is intact and the tumour carries antigens which are different to those of the host and therefore recognizably “foreign.”2.
openaire +2 more sources
Summary1. Experimental studies on immunity to tumours in animals show that tumour growth is modified by an immunological reaction provided that the immunological system of the host is intact and the tumour carries antigens which are different to those of the host and therefore recognizably “foreign.”2.
openaire +2 more sources
2009
A foremost objective of preclinical immunotoxicity testing is to address whether or not a drug or environmental toxicant causes adverse effects on net immune health, expressly the host's ability to mount an appropriate immune response to clear infectious organisms.
openaire +2 more sources
A foremost objective of preclinical immunotoxicity testing is to address whether or not a drug or environmental toxicant causes adverse effects on net immune health, expressly the host's ability to mount an appropriate immune response to clear infectious organisms.
openaire +2 more sources